Which has grown faster, AGIO or NVCR?

Over the past five years, NVCR grew revenue faster — AGIO at a 4.54% CAGR versus NVCR at 5.12%.

How have AGIO and NVCR total returns compared?

Over the past 10 years, AGIO delivered -5.39% and NVCR delivered 5.67% annualized total return. Past performance doesn't predict future results.

Agios Pharmaceuticals, Inc. (AGIO) vs Novocure Ltd (NVCR)

A side-by-side comparison of Agios Pharmaceuticals, Inc. and Novocure Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AGIO

Agios Pharmaceuticals, Inc.

$1.89B

$31.71HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT

NVCR

Novocure Ltd

$1.84B

$15.77HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT

Total return — AGIO vs NVCR

growth of $100 · dividends reinvested · last 10y

AGIO -40.8% (-5.1%/yr)NVCR +73.5% (+5.7%/yr)NVCR compounded faster over this window

AGIO NVCR

AGIO vs NVCR: by the numbers

•AGIO is the larger company ($1.89B vs $1.84B market cap).
•Both run net losses; NVCR's is the smaller (-21.25% vs -418.24% net margin).
•NVCR grew revenue faster over the past five years (5.12% vs 4.54% CAGR).

Metrics side by side

Valuation

Metric	AGIO	NVCR
P/S ratio	19.25	2.63
P/B ratio	1.85	5.43

Profitability

Metric	AGIO	NVCR
Gross margin	78.67%	76.13%
Operating margin	-873.87%	-22.08%
Net margin	-418.24%	-21.25%
ROE	-40.09%	-43.94%
ROIC	-44.21%	-26.88%

Growth (annualized)

Metric	AGIO	NVCR
Revenue CAGR (5Y)	4.54%	5.12%
Total return CAGR (5Y)	-6.59%	-32.71%

Frequently asked

Which has grown faster, AGIO or NVCR?: Over the past five years, NVCR grew revenue faster — AGIO at a 4.54% CAGR versus NVCR at 5.12%.
How have AGIO and NVCR total returns compared?: Over the past 10 years, AGIO delivered -5.39% and NVCR delivered 5.67% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AGIO analysis Full NVCR analysis Interactive comparison tool

Dig into the metrics

Agios Pharmaceuticals ROE Novocure ROE Agios Pharmaceuticals operating margin Novocure operating margin Agios Pharmaceuticals revenue growth Novocure revenue growth Agios Pharmaceuticals free cash flow Novocure free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.